Skip to main content

Brookstone Capital Management

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1599584 WHEATON, IL

Position in HALO

as of Jun 30, 2026 · filed Jul 15, 2026
Position Value
$863,474
-$3,067,285 QoQ
Shares Held
11,032
-82.1% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#20
of 62 holders
Holding Since
Jun 2021
17 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Brookstone Capital Management holds $3,313,596 across 9 Biotechnology names. HALO ranks #3 (26.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 HALO
Halozyme Therapeutics, Inc.
This page
11,032 $863,474

All Filings in HALO

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $863,474 11,032
2025-03-31 $3,930,759 61,601
2024-12-31 $2,896,664 60,587
2024-09-30 $3,467,999 60,587
2024-06-30 $3,230,454 61,697
2024-03-31 $2,510,362 61,710
2023-12-31 $2,228,983 60,308
2023-09-30 $2,304,835 60,336
2023-06-30 $2,179,169 60,415
2023-03-31 $2,307,248 60,415
2022-12-31 $3,431,639 60,310
2022-09-30 $2,384,657 60,310
2022-06-30 $2,655,180 60,345
2022-03-31 $2,405,162 60,310
2021-12-31 $2,425,065 60,310
2021-09-30 $2,453,410 60,310
2021-06-30 $2,738,677 60,310